Plunkett Research Online: Nephros Inc

NEPHROS INC (NEPH:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Nephros, Inc. is engaged in the development of hemodiafiltration, (HDF), products and technologies for treating patients with End Stage Renal Disease( ESRD). It has three products in various stages of development in the HDF modality to deliver improved therapy to ESRD patients: OLpur MDHDF filter se.....



Nephros Inc
Ticker: NEPH
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 201 343-5202
Fax: 212 781-5166
Address: 380 Lackawanna Place
South Orange, NJ 07079 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Electromedical and Electrotherapeutic Apparatus Manufacturing
ContactsDescription
Andrew AstorCFO/Chief Accounting Officer
Arthur AmronDirector
See More
Nephros, Inc. is engaged in the development of hemodiafiltration, (HDF), products and technologies for treating patients with End Stage Renal Disease( ESRD). It has three products in various stages of development in the HDF modality to deliver improved therapy to ESRD patients: OLpur MDHDF filter se.....See More See More

Auditor: Moody, Famiglietti & Andronico, LLP
Legal Advisor: Wyrick Robbins Yates & Ponton LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: